UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference
27 February 2024 - 12:00AM
Business Wire
- Presentation March 4, 2024 at 1:30 PM ET
-
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated
to developing and commercializing innovative solutions that treat
urothelial and specialty cancers, today announced that it will
present at TD Cowen’s 44th Annual Health Care Conference on Monday,
March 4, 2024 at 1:30pm EST.
TD Cowen 44th Annual Health Care Conference – March 4-6,
2024 Presentation: March 4, 2024 at 1:30 PM ET Location:
Boston, MA Webcast Link: TD Cowen 44th Annual Health Care
Conference (wsw.com)
A webcast from the conference will also be available via the
Investors section of UroGen’s website, www.urogen.com. A replay of
the webcast will be available for approximately 90 days.
About UroGen Pharma Ltd.
UroGen is a biotech company dedicated to developing and
commercializing innovative solutions that treat urothelial and
specialty cancers because patients deserve better options. UroGen
has developed RTGel® reverse-thermal hydrogel, a proprietary
sustained release, hydrogel-based platform technology that has the
potential to improve therapeutic profiles of existing drugs.
UroGen’s sustained release technology is designed to enable longer
exposure of the urinary tract tissue to medications, making local
therapy a potentially more effective treatment option. Jelmyto®
(mitomycin) for pyelocaliceal solution and investigational
treatment UGN-102 (mitomycin) for intravesical solution are
designed to ablate tumors by non-surgical means. UroGen is
headquartered in Princeton, NJ with operations in Israel. Visit
www.urogen.com to learn more or follow us on Twitter,
@UroGenPharma.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240226631566/en/
INVESTOR CONTACT: Vincent Perrone Senior Director, Investor
Relations vincent.perrone@urogen.com 609-460-3588 ext. 1093
MEDIA CONTACT: Cindy Romano Director, Corporate Communications
cindy.romano@urogen.com 609-460-3583 ext. 1083
UroGen Pharma (NASDAQ:URGN)
Historical Stock Chart
From Apr 2024 to May 2024
UroGen Pharma (NASDAQ:URGN)
Historical Stock Chart
From May 2023 to May 2024